Cancer Research UK logo.
SearchDonate
  • Search

A trial of trastuzumab deruxtecan and pertuzumab for breast cancer that has spread (DESTINY-breast09)

Overview

Cancer types:

Breast cancer, Secondary cancers

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at trastuzumab deruxtecan (T-DXd) with or without pertuzumab for breast cancer that has spread to another part of the body.

It is for people who have not had any treatment for their . Their cancer needs to have the .

Recruitment start: 4 October 2021

Recruitment end: 29 September 2023

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Caroline Michie

Supported by

AstraZeneca

Last reviewed: 29 Sept 2023

CRUK internal database number: 18321

Help and support